| 750508 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy |
2021-10-01 |
10.1136/jitc-2021-003671 |
Kortekaas Kim E, Santegoets Saskia J, Tas Liselotte, Ehsan Ilina, Charoentong Pornpimol, van Doorn Helena C, van Poelgeest Mariette I E, Mustafa Dana A M, van der Burg Sjoerd H |
| 750507 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma |
2021-10-01 |
10.1136/jitc-2021-003163 |
Evers Mitchell, Stip Marjolein, Keller Kaylee, Willemen Hanneke, Nederend Maaike, Jansen Marco, Chan Chilam, Budding Kevin, Nierkens Stefan, Valerius Thomas, Meyer-Wentrup Friederike, Eijkelkamp Niels, Leusen Jeanette |
| 750506 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis |
2021-10-01 |
10.1136/jitc-2021-002875 |
Yang Chenghui, Wang Zhen, Li Lili, Zhang Zhigang, Jin Xiaoyan, Wu Pin, Sun Shanshan, Pan Jun, Su Ke, Jia Fang, Zhang Leyi, Wang Haijun, Yu Xiuyan, Shao Xuan, Wang Ke, Qiu Fuming, Yan Jun, Huang Jian |
| 750505 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design |
2021-10-01 |
10.1136/jitc-2021-003149corr1 |
|
| 750504 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects |
2021-10-01 |
10.1136/jitc-2021-002505 |
Suarez-Carmona Meggy, Williams Anja, Schreiber Jutta, Hohmann Nicolas, Pruefer Ulrike, Krauss Jürgen, Jäger Dirk, Frömming Anna, Beyer Diana, Eulberg Dirk, Jungelius Jarf Ulf, Baumann Matthias, Mangasarian Aram, Halama Niels |
| 750503 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors |
2021-10-01 |
10.1136/jitc-2021-002797 |
Hwang Hee Sang, Kim Deokhoon, Choi Jene |
| 750502 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis |
2021-10-01 |
10.1136/jitc-2021-003473 |
Tzeng Alice, Tzeng Tony H, Ornstein Moshe C |
| 750501 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity |
2021-10-01 |
10.1136/jitc-2021-002980 |
Zhang Congcong, Röder Jasmin, Scherer Anne, Bodden Malena, Pfeifer Serrahima Jordi, Bhatti Anita, Waldmann Anja, Müller Nina, Oberoi Pranav, Wels Winfried S |
| 750500 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Nivolumab-associated DRESS in a genetic susceptible individual |
2021-10-01 |
10.1136/jitc-2021-002879 |
Ai Luoyan, Gao Jie, Zhao Shihai, Li Qian, Cui Yue-Hong, Liu Qing, Wu Duojiao, Wang Yimei, Jin Xiaoshi, Ji Yuan, Li Jingjie, Yu Yiyi, Liu Tianshu |
| 750499 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma |
2021-10-01 |
10.1136/jitc-2021-002955 |
Gibney Geoffrey T., Zaemes Jacob, Shand Shelly, Shah Neil J., Swoboda David, Gardner Kellie, Radfar Arash, Petronic-Rosic Vesna, Reilly Michael J., Al-Refaie Waddah B., Rapisuwon Suthee, Atkins Michael B. |
